Drugs / TargomiRs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02369198 | Sep 2014 → Jan 2017 | malignant pleural mesothelioma, non-small cell lung carcinoma | Asbestos Diseases Research Foundation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TargomiRs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02369198 ↗ |
| Route | Intravenous | “TargomiRs are IV injected.” NCT02369198 ↗ |